loadpatents
Patent applications and USPTO patent grants for Smith; Eric Michael.The latest application filed is for "anti-il-6 antibody".
Patent | Date |
---|---|
Anti-IL-6 Antibody App 20220048985 - Chen; Yan ;   et al. | 2022-02-17 |
Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody Grant 11,180,549 - Chen , et al. November 23, 2 | 2021-11-23 |
Methods of Suppressing Rheumatoid Arthritis Using an Anti-IL-6 Antibody App 20200115445 - Chen; Yan ;   et al. | 2020-04-16 |
Exercise Devices For Users In Confined Space App 20180229067 - Smith; Eric Michael | 2018-08-16 |
Methods of Suppressing Rheumatoid Arthritis Using An Anti-IL-6 Antibody App 20170253651 - Chen; Yan ;   et al. | 2017-09-07 |
Pen-injector device containing anti-IL-6 antibodies Grant 9,631,016 - Chen , et al. April 25, 2 | 2017-04-25 |
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20160222104 - Chen; Yan ;   et al. | 2016-08-04 |
Anti-IL-6 antibodies, compositions, methods and uses Grant 9,340,613 - Chen , et al. May 17, 2 | 2016-05-17 |
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20140099311 - Chen; Yan ;   et al. | 2014-04-10 |
Anti-IL-6 antibodies Grant 8,623,362 - Chen , et al. January 7, 2 | 2014-01-07 |
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20130017208 - Chen; Yan ;   et al. | 2013-01-17 |
Anti-IL-6 antibodies, compositions, methods and uses Grant RE43,672 - Chan , et al. September 18, 2 | 2012-09-18 |
Anti-sclerostin antibodies Grant 8,257,704 - Korytko , et al. September 4, 2 | 2012-09-04 |
Anti-IL-6 antibodies, compositions, methods and uses Grant 8,226,611 - Chen , et al. July 24, 2 | 2012-07-24 |
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20120045453 - CHEN; YAN ;   et al. | 2012-02-23 |
Methods of treating conditions using anti-IL-6 antibodies Grant 8,067,003 - Chen , et al. November 29, 2 | 2011-11-29 |
Anti-sclerostin Antibodies App 20110250205 - KORYTKO; Andrew Ihor ;   et al. | 2011-10-13 |
Methods of treatment comprising administering an anti-sclerostin antibody Grant 7,988,970 - Korytko , et al. August 2, 2 | 2011-08-02 |
Methods of Diagnosing and Treating Conditions Using Anti-IL-6 Antibodies App 20110081355 - CHEN; YAN ;   et al. | 2011-04-07 |
Humanized anti-ghrelin antibodies Grant 7,901,679 - Marquis , et al. March 8, 2 | 2011-03-08 |
Anti-IL-6 antibody nucleic acid molecules and methods Grant 7,833,755 - Chen , et al. November 16, 2 | 2010-11-16 |
Anti-Sclerostin Antibodies App 20100221263 - Korytko; Andrew Ihor ;   et al. | 2010-09-02 |
Anti-sclerostin antibodies Grant 7,744,874 - Korytko , et al. June 29, 2 | 2010-06-29 |
Anti-IL-6 Antibody Nucleic Acid Molecules and Methods App 20090239258 - Chen; Yan ;   et al. | 2009-09-24 |
Methods Of Optimizing Antibody Variable Region Binding Affinity App 20090202986 - Huse; William D. ;   et al. | 2009-08-13 |
Humanized Anti-ghrelin Antibodies App 20090181018 - Marquis; David Matthew ;   et al. | 2009-07-16 |
Anti-il-6 antibodies, compositions, methods and uses Grant 7,560,112 - Chen , et al. July 14, 2 | 2009-07-14 |
Anti-sclerostin Antibodies App 20090060924 - Korytko; Andrew Ihor ;   et al. | 2009-03-05 |
Anti-IL-6 antibodies, compositions, methods and uses App 20060257407 - Chen; Yan ;   et al. | 2006-11-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.